Get startedLog in
    Picture of Laboratorio Farmaceutico Erfo SpA logo

    ERFO — Laboratorio Farmaceutico Erfo SpA Cashflow Statement

    0.000.00%
    it flag iconLast trade - 00:00
    HealthcareSpeculativeMicro CapNeutral
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual cashflow statement for Laboratorio Farmaceutico Erfo SpA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.

    2020
    December 31st
    R2021
    December 31st
    2022
    December 31st
    2023
    December 31st
    2024
    December 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:ARSInterim ReportARSARSPRESS
    Standards:
    IAS
    IAS
    IAS
    IAS    		—
    Status:FinalFinalFinalFinalFinal
    Net Income/Starting Line1.141.170.7160.59—
    Depreciation
    Non-Cash Items0.3920.4590.3350.3—
    Unusual Items
    Other Non-Cash Items
    Changes in Working Capital-0.4390.206-0.91-0.3131.24
    Change in Accounts Receivable
    Change in Inventories
    Change in Prepaid Expenses
    Change in Accounts Payable
    Change in Accrued Expenses
    Net Change in Other Assets & Liabilities
    Other Operating Cash Flow
    Cash from Operating Activities1.382.270.7621.31.24
    Capital Expenditures-0.147-0.243-1.18-1.45—
    Purchase of Fixed Assets
    Purchase / Acquisition of Intangibles
    Other Investing Cash Flow Items-0.257-0.381-0.7010.346-0.95
    Sale of Fixed Assets
    Sale/Maturity of Investment
    Purchase of Investments
    Other Investing Cash Flow
    Cash from Investing Activities-0.404-0.624-1.88-1.1-0.95
    Financing Cash Flow Items-0.5-2.15-0.07-0.101-0.758
    Other Financing Cash Flow
    Total Cash Dividends Paid
    Net Issuance / Retirement of Stock
    Net Issuance / Retirement of Debt
    Cash from Financing Activities-0.328-2.182.22-0.824-0.758
    Beginning Cash Balance
    Ending Cash Balance
    Net Change in Cash0.652-0.5281.1-0.627-0.467